Fresenius Medical Care (FMS) Tops Q2 EPS by 33c

Fresenius Medical Care (NYSE: FMS) reported Q2 EPS of EUR0.70, EUR0.33 better than the analyst estimate of EUR0.37. Revenue for the quarter came in at EUR4.77 billion versus the consensus estimate of EUR5.44 billion.

For earnings history and earnings-related data on Fresenius Medical Care (FMS) click here.

You May Also Be Interested In

• Gulfport Energy and Mobility Global to join S&P SmallCap 600
• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
• FDA approves AbbVie's Skyrizi for children with psoriatic disease